These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35216318)

  • 1. Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4
    Yeregui E; Masip J; Viladés C; Domingo P; Pacheco YM; Blanco J; Mallolas J; Alba V; Vargas M; García-Pardo G; Negredo E; Olona M; Vidal-González J; Peraire M; Martí A; Reverté L; Gómez-Bertomeu F; Leal M; Vidal F; Peraire J; Rull A
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial Functions Are Compromised in CD4 T Cells From ART-Controlled PLHIV.
    Zhao J; Schank M; Wang L; Li Z; Nguyen LN; Dang X; Cao D; Khanal S; Nguyen LNT; Thakuri BKC; Ogbu SC; Lu Z; Wu XY; Morrison ZD; Gazzar ME; Liu Y; Zhang J; Ning S; Moorman JP; Yao ZQ
    Front Immunol; 2021; 12():658420. PubMed ID: 34017335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced immune reconstitution with albuvirtide in HIV-infected immunological non-responders.
    Fan L; Hu Y; Li R; Ding J; Liu Y; Yu S; Hu M; Su R; Li Y; Yu A; Xie D; Zhao Q; Ma P
    Front Cell Infect Microbiol; 2024; 14():1397743. PubMed ID: 38975330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy.
    Scherpenisse M; Kootstra NA; Bakker M; Berkhout B; Pasternak AO
    mBio; 2021 Mar; 12(2):. PubMed ID: 33688002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5 genotype and pre-treatment CD4+ T-cell count influence immunological recovery of HIV-positive patients during antiretroviral therapy.
    Carvalho-Silva WHV; Andrade-Santos JL; Guedes MCDS; Crovella S; Guimarães RL
    Gene; 2020 May; 741():144568. PubMed ID: 32165289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy.
    Negredo E; Massanella M; Puertas MC; Buzón MJ; Puig J; Pérez-Alvárez N; Pérez-Santiago J; Bonjoch A; Moltó J; Jou A; Echeverría P; Llibre JM; Martínez-Picado J; Clotet B; Blanco J
    J Antimicrob Chemother; 2013 Oct; 68(10):2358-62. PubMed ID: 23677919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive role of CD4
    Li CX; Li YY; He LP; Kou J; Bai JS; Liu J; Tian B; Cao LJ; Wang KH; Kuang YQ
    BMC Immunol; 2019 Aug; 20(1):31. PubMed ID: 31455209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
    Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
    J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study.
    Liu ZY; Guo FP; Han Y; Qiu ZF; Zuo LY; Li YL; Li TS
    Chin Med J (Engl); 2009 Oct; 122(20):2497-502. PubMed ID: 20079166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV immunological non-responders are characterized by extensive immunosenescence and impaired lymphocyte cytokine production capacity.
    Vos WAJW; Navas A; Meeder EMG; Blaauw MJT; Groenendijk AL; van Eekeren LE; Otten T; Vadaq N; Matzaraki V; van Cranenbroek B; Brinkman K; van Lunzen J; Joosten LAB; Netea MG; Blok WL; van der Ven AJAM; Koenen HJPM; Stalenhoef JE
    Front Immunol; 2024; 15():1350065. PubMed ID: 38779686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher CD27+CD8+ T cells percentages during suppressive antiretroviral therapy predict greater subsequent CD4+ T cell recovery in treated HIV infection.
    Seu L; Ortiz GM; Epling L; Sinclair E; Swainson LA; Bajpai UD; Huang Y; Deeks SG; Hunt PW; Martin JN; McCune JM
    PLoS One; 2013; 8(12):e84091. PubMed ID: 24391889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in circulating immunoregulatory proteins discriminate poor CD4 T lymphocyte trajectories in people with HIV on suppressive antiretroviral therapy.
    Moar P; Bowler S; Landay AL; Gianella S; Ndhlovu LC; Premeaux TA
    mBio; 2024 Oct; 15(10):e0226524. PubMed ID: 39287441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV/antiretroviral therapy-related lipodystrophy syndrome (HALS) is associated with higher RBP4 and lower omentin in plasma.
    Peraire J; López-Dupla M; Alba V; Beltrán-Debón R; Martinez E; Domingo P; Asensi V; Leal M; Viladés C; Inza MI; Escoté X; Arnedo M; Mateo G; Valle-Garay E; Ferrando-Martinez S; Veloso S; Vendrell J; Gatell JM; Vidal F;
    Clin Microbiol Infect; 2015 Jul; 21(7):711.e1-8. PubMed ID: 25882366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in blood microbial lipopolysaccharide (LPS) contributes to immune reconstitution in response to suppressive antiretroviral therapy in HIV.
    Luo Z; Health SL; Li M; Yang H; Wu Y; Collins M; Deeks SG; Martin JN; Scott A; Jiang W
    EBioMedicine; 2022 Jun; 80():104037. PubMed ID: 35500539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART.
    Marchetti G; Gori A; Casabianca A; Magnani M; Franzetti F; Clerici M; Perno CF; Monforte Ad; Galli M; Meroni L
    AIDS; 2006 Aug; 20(13):1727-36. PubMed ID: 16931937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis.
    Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Makutu DK; Nfanyana K; Rantleru T; Tierney A; Nkakana K; Schwartz AB; Gross R; Macgregor RR; Bellamy SL; Frank I; Weissman D; Bisson GP
    J Infect Dis; 2013 Dec; 208(11):1784-93. PubMed ID: 23908475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymic Function as a Predictor of Immune Recovery in Chronically HIV-Infected Patients Initiating Antiretroviral Therapy.
    Rb-Silva R; Nobrega C; Azevedo C; Athayde E; Canto-Gomes J; Ferreira I; Cheynier R; Yates AJ; Horta A; Correia-Neves M
    Front Immunol; 2019; 10():25. PubMed ID: 30804925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of HIV reservoir decay and naïve CD4 T-cell recovery between immune non-responders and complete responders on long-term antiretroviral treatment.
    Zhang LX; Song JW; Zhang C; Fan X; Huang HH; Xu RN; Liu JY; Zhang JY; Wang LF; Zhou CB; Jin L; Shi M; Wang FS; Jiao YM
    Clin Immunol; 2021 Aug; 229():108773. PubMed ID: 34102315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD; Keruly JC
    Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
    Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
    Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.